Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals.

Falagas ME, Voulgaris GL, Tryfinopoulou K, Giakkoupi P, Kyriakidou M, Vatopoulos A, Coates A, Hu Y; Colistin - Azidothymidine Hellenic Study Group.

Int J Antimicrob Agents. 2019 Jun;53(6):855-858. doi: 10.1016/j.ijantimicag.2019.02.021. Epub 2019 Mar 2.

PMID:
30836109
2.

Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy.

Papagiannitsis CC, Di Pilato V, Giani T, Giakkoupi P, Riccobono E, Landini G, Miriagou V, Vatopoulos AC, Rossolini GM.

J Antimicrob Chemother. 2016 Oct;71(10):2824-30. doi: 10.1093/jac/dkw227. Epub 2016 Jun 21.

PMID:
27334661
3.

Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: A pilot study.

Aqel AA, Giakkoupi P, Alzoubi H, Masalha I, Ellington MJ, Vatopoulos A.

J Infect Public Health. 2017 Mar - Apr;10(2):150-155. doi: 10.1016/j.jiph.2016.02.002. Epub 2016 Mar 15.

4.

Characterisation of IncA/C2 plasmids carrying an In416-like integron with the blaVIM-19 gene from Klebsiella pneumoniae ST383 of Greek origin.

Papagiannitsis CC, Dolejska M, Izdebski R, Giakkoupi P, Skálová A, Chudějová K, Dobiasova H, Vatopoulos AC, Derde LP, Bonten MJ, Gniadkowski M, Hrabák J.

Int J Antimicrob Agents. 2016 Feb;47(2):158-62. doi: 10.1016/j.ijantimicag.2015.12.001. Epub 2015 Dec 19.

PMID:
26795022
5.

Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area.

Giakkoupi P, Tryfinopoulou K, Polemis M, Pappa O, Miriagou V, Vatopoulos A.

Diagn Microbiol Infect Dis. 2015 May;82(1):62-4. doi: 10.1016/j.diagmicrobio.2015.02.009. Epub 2015 Feb 23.

PMID:
25752202
6.

Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone.

Adler A, Khabra E, Chmelnitsky I, Giakkoupi P, Vatopoulos A, Mathers AJ, Yeh AJ, Sifri CD, De Angelis G, Tacconelli E, Villegas MV, Quinn J, Carmeli Y.

Diagn Microbiol Infect Dis. 2014 Jan;78(1):12-5. doi: 10.1016/j.diagmicrobio.2013.10.003. Epub 2013 Oct 14.

PMID:
24231383
7.

Emergence of NDM-producing Klebsiella pneumoniae in Greece.

Giakkoupi P, Tryfinopoulou K, Kontopidou F, Tsonou P, Golegou T, Souki H, Tzouvelekis L, Miriagou V, Vatopoulos A.

Diagn Microbiol Infect Dis. 2013 Dec;77(4):382-4. doi: 10.1016/j.diagmicrobio.2013.09.001. Epub 2013 Oct 14. No abstract available.

PMID:
24135413
8.

OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae.

Papagiannitsis CC, Giakkoupi P, Kotsakis SD, Tzelepi E, Tzouvelekis LS, Vatopoulos AC, Miriagou V.

J Chemother. 2013 Aug;25(4):250-4. doi: 10.1179/1973947813Y.0000000075. No abstract available.

PMID:
23906079
9.

Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase.

Papagiannitsis CC, Miriagou V, Giakkoupi P, Tzouvelekis LS, Vatopoulos AC.

J Antimicrob Chemother. 2013 Oct;68(10):2259-62. doi: 10.1093/jac/dkt196. Epub 2013 May 27.

PMID:
23711894
10.

Characterization of pKP1433, a novel KPC-2-encoding plasmid from Klebsiella pneumoniae sequence type 340.

Papagiannitsis CC, Miriagou V, Giakkoupi P, Tzouvelekis LS, Vatopoulos AC.

Antimicrob Agents Chemother. 2013 Jul;57(7):3427-9. doi: 10.1128/AAC.00054-13. Epub 2013 Apr 29.

11.

Dissemination of blaVIM in Greece at the peak of the epidemic of 2005-2006: clonal expansion of Klebsiella pneumoniae clonal complex 147.

Hasan CM, Turlej-Rogacka A, Vatopoulos AC, Giakkoupi P, Maâtallah M, Giske CG.

Clin Microbiol Infect. 2014 Jan;20(1):34-7. doi: 10.1111/1469-0691.12187. Epub 2013 Mar 7.

12.

Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.

Papagiannitsis CC, Tryfinopoulou K, Giakkoupi P, Pappa O, Polemis M, Tzelepi E, Tzouvelekis LS; Carbapenemase Study Group, Vatopoulos AC.

Int J Antimicrob Agents. 2012 Feb;39(2):178-80. doi: 10.1016/j.ijantimicag.2011.09.024. Epub 2011 Nov 21. No abstract available.

PMID:
22104281
13.

An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).

Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC.

J Antimicrob Chemother. 2011 Jul;66(7):1510-3. doi: 10.1093/jac/dkr166. Epub 2011 May 4.

PMID:
21543359
14.

Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.

Papagiannitsis CC, Giakkoupi P, Vatopoulos AC, Tryfinopoulou K, Miriagou V, Tzouvelekis LS.

Int J Antimicrob Agents. 2010 Dec;36(6):573-4. doi: 10.1016/j.ijantimicag.2010.07.018. Epub 2010 Sep 21. No abstract available.

PMID:
20863669
15.

Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain.

Barbier F, Ruppé E, Giakkoupi P, Wildenberg L, Lucet J, Vatopoulos A, Wolff M, Andremont A.

Euro Surveill. 2010 Jan 7;15(1). pii: 19457. Erratum in: Euro Surveill. 2010 Jan 14;15(2). pii/19460.

16.

Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.

Giakkoupi P, Pappa O, Polemis M, Vatopoulos AC, Miriagou V, Zioga A, Papagiannitsis CC, Tzouvelekis LS.

Antimicrob Agents Chemother. 2009 Sep;53(9):4048-50. doi: 10.1128/AAC.00690-09. Epub 2009 Jul 6. No abstract available.

17.

Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).

Maltezou HC, Giakkoupi P, Maragos A, Bolikas M, Raftopoulos V, Papahatzaki H, Vrouhos G, Liakou V, Vatopoulos AC.

J Infect. 2009 Mar;58(3):213-9. doi: 10.1016/j.jinf.2009.01.010. Epub 2009 Feb 26.

PMID:
19246099
18.

A multiresistant Klebsiella pneumoniae clinical isolate carrying both CTX-M-15 and VIM-1 beta-lactamases, harboured by different plasmids.

Giakkoupi P, Vourli S, Vatopoulos AC, Kanellopoulou M, Papafrangas E, Raitsiu B.

Int J Antimicrob Agents. 2009 Feb;33(2):191-2. doi: 10.1016/j.ijantimicag.2008.08.008. Epub 2008 Oct 23. No abstract available.

PMID:
18950991
19.

Epidemiology of metalloenzyme-producing Pseudomonas aeruginosa in a tertiary hospital in Greece.

Zappas S, Giakkoupi P, Vourli S, Hadjichristodoulou C, Polemis M, Tzouvelekis LS, Avlami A, Vatopoulos A, Daikos GL, Petrikkos G.

J Chemother. 2008 Jun;20(3):307-11.

PMID:
18606584
20.

Supplementation of growth media with Zn2+ facilitates detection of VIM-2-producing Pseudomonas aeruginosa.

Giakkoupi P, Vourli S, Polemis M, Kalapothaki V, Tzouvelekis LS, Vatopoulos AC.

J Clin Microbiol. 2008 Apr;46(4):1568-9. doi: 10.1128/JCM.02345-07. Epub 2008 Feb 20. No abstract available.

21.

Transferable DHA-1 cephalosporinase in Escherichia coli.

Giakkoupi P, Tambic-Andrasevic A, Vourli S, Skrlin J, Sestan-Crnek S, Tzouvelekis LS, Vatopoulos AC.

Int J Antimicrob Agents. 2006 Jan;27(1):77-80. Epub 2005 Dec 13.

PMID:
16352422
22.

Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.

Giakkoupi P, Tzouvelekis LS, Daikos GL, Miriagou V, Petrikkos G, Legakis NJ, Vatopoulos AC.

J Clin Microbiol. 2005 Jan;43(1):494-6.

23.

Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.

Vourli S, Giakkoupi P, Miriagou V, Tzelepi E, Vatopoulos AC, Tzouvelekis LS.

FEMS Microbiol Lett. 2004 May 15;234(2):209-13.

24.

VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals.

Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miriagou V, Kontou S, Papafraggas E, Malamou-Lada H, Tzouvelekis LS, Legakis NJ, Vatopoulos AC.

J Clin Microbiol. 2003 Aug;41(8):3893-6.

25.

Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals.

Giakkoupi P, Petrikkos G, Tzouvelekis LS, Tsonas S, Legakis NJ, Vatopoulos AC; WHONET Greece Study Group.

J Clin Microbiol. 2003 Feb;41(2):822-5.

26.

Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.

Giakkoupi P, Hujer AM, Miriagou V, Tzelepi E, Bonomo RA, Tzouvelekis LS.

FEMS Microbiol Lett. 2001 Jul 10;201(1):37-40.

27.

IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.

Giakkoupi P, Tzouvelekis LS, Tsakris A, Loukova V, Sofianou D, Tzelepi E.

Antimicrob Agents Chemother. 2000 Sep;44(9):2247-53.

28.

Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A.

J Clin Microbiol. 2000 Feb;38(2):542-6.

29.

Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.

Giakkoupi P, Tzelepi E, Tassios PT, Legakis NJ, Tzouvelekis LS.

J Antimicrob Chemother. 2000 Jan;45(1):101-4.

PMID:
10629019
30.

Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.

Giakkoupi P, Tzelepi E, Legakis NJ, Tzouvelekis LS.

J Antimicrob Chemother. 1999 Jan;43(1):23-9.

PMID:
10381097
31.

Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.

Giakkoupi P, Miriagou V, Gazouli M, Tzelepi E, Legakis NJ, Tzouvelekis LS.

Antimicrob Agents Chemother. 1998 May;42(5):1281-3.

32.
33.

Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.

Tzouvelekis LS, Tzelepi E, Prinarakis E, Gazouli M, Katrahoura A, Giakkoupi P, Paniara O, Legakis NJ.

J Clin Microbiol. 1998 Jan;36(1):266-8.

Supplemental Content

Loading ...
Support Center